Back to catalog
Tesamorlin Astral research vial

Tesamorlin

TH9507

A stabilized 44-amino-acid analog of growth-hormone-releasing hormone. Supplied as a reference compound for in-vitro GHRH-receptor and endocrine-signaling research.

Mass

  • 10 mg$72.99In stock

From $72.99Purity 98.165%Third-party tested— View COA

View purchase options

Specifications

Tesamorlin — Specifications
CAS number218949-48-5
Molecular formulaC221H366N72O67S
Molecular weight5135.86 g/mol
FormLyophilized powder
Purity (latest released COA)98.165% · AST-TM10-001
Net quantity10 mg / vial

Handling & storage

Tesamorlin — Handling & storage
GuidanceStore lyophilized powder at −20 °C, protected from light. After reconstitution with bacteriostatic water, store at 2–8 °C and use within 30 days. Every vial ships with a batch-specific Certificate of Analysis.
For laboratory research use only. Not a drug, food, cosmetic or supplement. Not for human or veterinary consumption, diagnosis, or treatment.

Documentation

Certificates of Analysis

Batch-specific, third-party lab certificates. Each COA is published here once its lot has been tested — preview the results, then open the full PDF.

Current released record

AST-TM10-001

Dosage
10 mg
Purity
98.165%
Laboratory
Janoshik Analytical
Analyzed
2026-07-27
Open source PDF

View the compound COA record →

Related peer-reviewed research

  1. Advances in the detection of growth hormone releasing hormone synthetic analogs. Drug Testing and Analysis (2021)